[1] |
van Erning FN, Mackay TM, van der Geest LGM,et al. Association of the location of pancreatic ductal adenocarcinoma(head,body,tail)with tumor stage,treatment,and survival: a population-based analysis[J]. Acta Oncol,2018:1-8.
|
[2] |
Sahin IH, Elias H, Chou JF,et al. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior[J]. BMC Cancer,2018,18(1):769.
|
[3] |
He C, Zhang Y, Cai Z,et al. Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis[J]. J Cancer,2018,9(17):3156-3167.
|
[4] |
Tempero MA, Malafa MP, Al-Hawary M,et al. Pancreatic Adenocarcinoma,Version 2.2017,NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw,2017,15(8):1028-1061.
|
[5] |
Wang WQ, Liu L, Ni QX,et al. Guidelines for the diagnosis and treatment of pancreatic adenocarcinoma(2018 edition): A standardized procedure recommended in China[J]. HBPD INT,2018,17(5):383-384.
|
[6] |
Al-Husseini MJ, Saad AM, Turk T,et al. Impact of prior malignancy on survival outcomes of stage IV pancreatic adenocarcinoma: SEER-Based Cohort[J]. J Gastrointest Cancer,2018. [Epub ahead of print]
|
[7] |
Huang KW, Yang PC, Pua U,et al. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma[J]. J Surg Oncol,2018,118(1):31-36.
|
[8] |
D'Onofrio M, Barbi E, Girelli R,et al. Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma[J]. J Gastrointest Oncol,2016,7(2):213-220.
|
[9] |
Nabavizadeh A, Payen T, Saharkhiz N,et al. Technical Note: In vivo Young's modulus mapping of pancreatic ductal adenocarcinoma during HIFU ablation using harmonic motion elastography(HME)[J]. Med Phys,2018,45(11):5244-5250.
|
[10] |
Xu JB, Yang XC, Guo JH,et al. Serum nerve growth factor level indicates therapeutic efficacy of 125I seed implantation in advanced pancreatic adenocarcinoma[J]. Eur Rev Med Pharmacol Sci,2015,19(18):3385-3390.
|
[11] |
Pacella CM. Ultrasound-guidedpercutonous laser ablation of liver tissue in a rabbit model[J]. European Radiology,1993,3(5):479-479.
|
[12] |
Tian G, Jiang T. US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report[J]. Medicine(Baltimore),2017,96(15):e6597.
|
[13] |
Morton LM, Kerns SL, Dolan ME. Role of germline genetics in identifying survivors at risk for adverse effects of cancer treatment[J]. Am Soc Clin Oncol Educ Book,2018,(38):775-786.
|
[14] |
Morse B, Jeong D, Ihnat G,et al. Pearls and pitfalls of response evaluation criteria in solid tumors(RECIST)v1.1 non-target lesion assessment[J]. Abdom Radiol(NY),2018. [Epub ahead of print]
|
[15] |
Mizota A, Takasoh M, Kobayashi K,et al. Internal sclerostomy with the Er: YAG laser using a gradient-index(GRIN)endoscope[J]. Ophthalmic Surg Lasers,2002,33(3):214-220.
|
[16] |
Moyer MT, Sharzehi S, Mathew A,et al. The safety and efficacy of an alcohol-free pancreatic cyst ablation protocol[J]. Gastroenterology,2017,153(5):1295-1303.
|
[17] |
Date RS, Siriwardena AK. Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome[J]. JOP,2005,6(6):588-592.
|
[18] |
Spiliotis JD, Datsis AC, Michalopoulos NV,et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas[J]. Langenbecks Arch Surg,2007,392(1):55-60.
|
[19] |
Zou YP, Li WM, Zheng F,et al. Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer[J]. World J Gastroenterol,2010,16(40):5104-5110.
|
[20] |
Schena E, Saccomandi P, Fong Y. Laser ablation for cancer: past,present and future[J]. J Funct Biomater,2017,8(2):E19.
|
[21] |
Wang ZJ, Behr S, Consunji MV,et al. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI[J]. AJR Am J Roentgenol,2018,211(5):1010-1019.
|